Fhit Gene Dynamics in Cancer Pathogenesis

The fragile histidine triad (FHIT) gene encodes a tumour suppressor localised at the common fragile site FRA3B on chromosome 3. FHIT loss or inactivation by deletion, loss of heterozygosity or promoter methylation is among the earliest events in many epithelial cancers. Disruption of FHIT expression compromises replication fork progression, leading to DNA breakage, chromosomal rearrangements and genome instability without triggering cell cycle arrest. FHIT depletion also alters the translation of cancer‐associated mRNAs and diminishes mitochondrial reactive oxygen species–mediated apoptosis through impaired interaction with key partners. Taken together, these dynamics position FHIT as a caretaker of genomic integrity whose inactivation fosters mutation accumulation, clonal expansion and tumour initiation. Beyond mechanistic insights, FHIT status has emerged as a potential biomarker for early detection and a candidate target for therapies aimed at restoring its genome‐protective and pro‐apoptotic functions.

Research from Nature Portfolio

Recent studies have quantified the influence of environmental pressures on FHIT variants by analysing single nucleotide polymorphism frequencies across populations and habitats. One investigation mapped adaptive forces acting on an intronic FHIT variant linked to rodent zoonotic reservoirs, revealing that environmental factors such as host species richness can shape the distribution of alleles at the FRA3B locus. This work underscores the sensitivity of FHIT to external carcinogens and suggests that gene–environment interactions contribute to early FHIT loss in tumourigenesis.

Fhit Gene Dynamics in Cancer Pathogenesis publication trend

The graph below shows the total number of articles in fhit gene dynamics in cancer pathogenesis across all publications each year (not limited to Nature Index journals).

Technical terms

FHIT gene: A tumour suppressor located at the FRA3B common fragile site, frequently deleted or silenced in cancers.

Common fragile site: Chromosomal regions prone to breakage under replication stress, often hosting tumour suppressor genes.

Tumour suppressor: A gene that protects cells from progressing to malignancy by regulating DNA repair, apoptosis or cell cycle checkpoints.

Replication stress: A state in which DNA replication is impeded, leading to fork stalling, collapse and genomic instability.

Loss of heterozygosity (LOH): The deletion or inactivation of one allele at a gene locus, reducing gene dosage and function.

Promoter methylation: The addition of methyl groups to DNA promoter regions, often silencing gene transcription.

Single nucleotide polymorphism (SNP): A single base-pair variation in the genome that may affect gene function or regulation.

References

1. The Rosetta Stone Hypothesis-Based Interaction of the Tumor Suppressor Proteins Nit1 and Fhit. Cells (2023).
2. Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev. Cancers (2023).
3. Evidence of cancer-linked rodent zoonoses from biophysical genomic variations. Scientific Reports (2023).
4. Impact of FHIT loss on the translation of cancer-associated mRNAs. Molecular Cancer (2017).
5. Fhit–Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells. Cell Death & Disease (2019).
6. Initiation of Genome Instability and Preneoplastic Processes through Loss of Fhit Expression. PLOS Genetics (2012).
7. Fhit Deficiency-Induced Global Genome Instability Promotes Mutation and Clonal Expansion. PLOS ONE (2013).